Therapeutic efficacy of hydrogen‑rich saline alone and in combination with PI3K inhibitor in non‑small cell lung cancer.
Jiang Y, Liu G, Zhang L, Cheng S, Luo C, Liao Y, Guo S · Molecular medicine reports · 2018
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
Molecular hydrogen produced a favorable primary result in this laboratory study, supporting further research into its potential for lung cancer.
Hydrogen-rich saline lung cancer study 2018: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This uncontrolled human study examined Therapeutic efficacy of hydrogen‑rich saline alone and in combination with PI3K inhibitor in non‑small cell lung cancer. The abstract describes Human participants; hydrogen delivered as hydrogen-rich saline. Similarly, the results of the present study demonstrated that administration of the two agents in combination may inhibit phospho‑Akt activity, and reduce expression of….
Publication: Jiang Y, Liu G, Zhang L, Cheng S, Luo C, Liao Y, Guo S, Molecular medicine reports, 2018.
What the researchers studied
The aim of the present study was to investigate the effects of combination therapy of LY294002, a specific inhibitor of phosphatidylinositol 3‑kinase (PI3K), with hydrogen‑rich…
What effects did molecular hydrogen have?
Observed hydrogen effects: Similarly, the results of the present study demonstrated that administration of the two agents in combination may inhibit phospho‑Akt activity, and reduce expression of… The aim of the present study was to investigate the effects of combination therapy of LY294002, a specific inhibitor of phosphatidylinositol 3‑kinase (PI3K), with hydrogen‑rich saline on the proliferation and apoptosis (programmed cell death) of the non‑small cell lung cancer (NSCLC) A549 cell line and the mechanisms underpinning this.
Why these findings matter
The result supports a plausible mechanism through which hydrogen-rich saline could influence lung cancer. Mechanistic cell findings help explain therapeutic potential, but they do not establish a health benefit in a living person.
How strong is this evidence?
This is laboratory or cellular evidence. It is useful for understanding mechanisms but is several steps removed from demonstrating a patient benefit.
Technical study details
- Publication type: In vitro or cellular study
- Evidence type: Laboratory or cellular evidence
- Research model or population: A549 lung adenocarcinoma cell line
- Hydrogen method: Hydrogen-rich saline
Limitations and safety
Important limitations: The abstract alone may not report all methodological limitations; full-text review is required.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.